{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:18:43Z","timestamp":1788304723538,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":4335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jpainsymman.2007.04.016","type":"journal-article","created":{"date-parts":[[2008,1,8]],"date-time":"2008-01-08T10:33:00Z","timestamp":1199788380000},"page":"314-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Morphine Bioavailability from a Topical Gel Formulation in Volunteers"],"prefix":"10.1016","volume":"35","author":[{"given":"Judith A.","family":"Paice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie H.","family":"Von Roenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Craig","family":"Hudgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom C.","family":"Krejcie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Avram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2007.04.016_bib1","first-page":"215","article-title":"Alternatives to oral opioids for cancer pain","volume":"13","author":"Mercadante","year":"1999","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib2","doi-asserted-by":"crossref","first-page":"E281","DOI":"10.1208\/aapsj070229","article-title":"Drug compounding for veterinary patients","volume":"7","author":"Papich","year":"2005","journal-title":"AAPS J"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib3","doi-asserted-by":"crossref","first-page":"E298","DOI":"10.1208\/pt060240","article-title":"Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review","volume":"6","author":"Kumar","year":"2005","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3959(98)00211-5","article-title":"Potential uses of topical opioids in palliative care\u2014report of 6 cases","volume":"80","author":"Krajnik","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib5","first-page":"39","article-title":"Chronic arthritis pain management with topical morphine: case series","volume":"19","author":"Wilken","year":"2005","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2125.2000.00141.x","article-title":"The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine","volume":"49","author":"Stuart-Harris","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/dmd.106.010652","article-title":"Recirculatory pharmacokinetic model of the uptake, distribution, and bioavailability of prochlorperazine administered as a thermally generated aerosol in a single breath to dogs","volume":"35","author":"Avram","year":"2007","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.jpainsymman.2007.04.016_bib8","first-page":"S48","article-title":"Topical morphine bioavailability in volunteers","volume":"8","author":"Paice","year":"2007","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib9","series-title":"The Hospice Pharmacia Pharmaceutical Care Tool Kit\u2122","year":"2004"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/J354v16n04_02","article-title":"Clinical pharmacokinetics of morphine","volume":"16","author":"Lugo","year":"2002","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0026-0495(98)90064-6","article-title":"SAAM II: Simulation, analysis, and modeling software for tracer and pharmacokinetic studies","volume":"47","author":"Barrett","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib12","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0009-9236(97)90079-5","article-title":"Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system","volume":"62","author":"Ward","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00007691-199101000-00001","article-title":"Clinical pharmacokinetics of morphine","volume":"13","author":"Glare","year":"1991","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0304-3959(02)00205-1","article-title":"A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia","volume":"99","author":"Vase","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1023\/A:1015944018555","article-title":"Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin","volume":"6","author":"Roy","year":"1989","journal-title":"Pharm Res"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib16","first-page":"202","article-title":"Evaluation of transdermal morphine and fentanyl pluronic lecithin organogel administration in dogs","volume":"5","author":"Krotscheck","year":"2004","journal-title":"Vet Ther"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib17","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jpainsymman.2003.09.011","article-title":"The bioavailability of morphine applied topically to cutaneous ulcers","volume":"27","author":"Ribeiro","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0885-3924(03)00146-5","article-title":"Analgesic efficacy of morphine applied topically to painful ulcers","volume":"25","author":"Zeppetella","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/1389201033489766","article-title":"Peripheral opioid analgesia","volume":"4","author":"Janson","year":"2003","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/bja\/85.2.228","article-title":"Effect of peripheral morphine in a human model of acute inflammatory pain","volume":"85","author":"Lilleso","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2125.1994.tb04306.x","article-title":"Transdermal administration of morphine to healthy subjects","volume":"37","author":"Westerling","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00003088-200038010-00004","article-title":"Clinical pharmacokinetics of transdermal opioids: Focus on transdermal fentanyl","volume":"38","author":"Grond","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0304-3959(89)90130-9","article-title":"The transdermal administration of fentanyl in the treatment of postoperative pain: pharmacokinetics and pharmacodynamic effects","volume":"37","author":"Gourlay","year":"1989","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1470-2045(00)00258-8","article-title":"Treatment of cancer pain with transdermal fentanyl","volume":"2","author":"Gourlay","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jpainsymman.2007.04.016_bib25","first-page":"267","article-title":"A review of pluronic lecithin organogel as a topical and transdermal drug delivery system","volume":"12","author":"Murdan","year":"2005","journal-title":"Hospital Pharmacist"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392407006744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392407006744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:59:19Z","timestamp":1760129959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392407006744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0885392407006744"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.04.016","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morphine Bioavailability from a Topical Gel Formulation in Volunteers","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}